National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Health Disorders
The goal of the NCDDG program is to advance the discovery, preclinical development, and early proof of concept testing in humans of new pharmacologic and neuromodulatory approaches to treat mental disorders, and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug and device targets.
Related Posts
Collaborative Care Could Help Reduce Disparities in Mental Health Treatment
July 2, 2024
In an NIMH-funded study, a comprehensive collaborative care intervention...
Technical Assistance Webinar: Streamlining Mental Health Interventions for Youth Living with HIV in Low-and Middle-Income Countries
June 15, 2024
A technical assistance webinar will be held for prospective applicants of the...
Pathways to Recovery: Psychosis and Schizophrenia
May 9, 2024
Psychosis, a condition marked by a loss of touch with reality, is distressing for...
NIMH Genomics Team 75th Anniversary Webinar: Celebrating Advancements in Psychiatric Genomics
May 28, 2024
As part of the yearlong 75th Anniversary celebration, the National Institute of...